Novavax beat third-quarter expectations as product sales strengthened and raised its 2026 outlook. Shares fell Thursday, Nov. 5, as the company revised its profitability forecast.
The company also changed its expectations for profitability.
Business / Investing
Add as a preferred source on GoogleNovavax Lifts 2026 Outlook After Q3 Beat, but Shares Fall
Product sales helped Novavax beat quarterly expectations, while the company adjusted its profitability forecast.
Updated 1 min read
Related articles
Business
AppLovin Revenue Climbs 55% as Fourth-Quarter Outlook Beats Expectations
The advertising technology company forecast fourth-quarter revenue of $2.365 billion to $2.395 billion and adjusted EBITDA of $1.995 billion to $2.025 billion.
Business
Lleida.net Posts First 2026 Quarterly Sales Gain as Notification and Other SaaS Rise
Registered Electronic Notification and Other SaaS accounted for 27.3% of quarterly sales; the consolidated figures were unaudited.
Investing
Morgan Stanley Lowers Cisco Rating to Equal-Weight Ahead of Earnings
The bank changed its rating Nov. 5, seven days before Cisco's scheduled Nov. 12 report; shares were 2.9% lower in premarket trading that day.